Is Mitotane expensive to sell in hospitals?

Mitotane (Mitotane) is an oral drug that specifically targets adrenocortical cells and is mainly used for the treatment of adrenocortical carcinoma (ACC; adrenal cancer). It can be used as adjuvant therapy after surgery to reduce the risk of tumor recurrence, and is also suitable for patients with advanced or metastatic disease that cannot be surgically removed. Mitotane has a unique mechanism of action by selectively destroying adrenocortical cells and inhibiting cortical hormone synthesis, thereby inhibiting tumor growth and abnormal hormone secretion. Since adrenocortical cancer is a rare tumor, mitotane has irreplaceable clinical importance and is one of the core drugs in the treatment plan for ACC.

In the domestic market, the original drug of mitotane is already on the market, but it has not yet been included in medical insurance, so patients need to purchase it at their own expense. The specifications are 500mg and 100 tablets per box, and the price may be more than 9,000 yuan, which is a considerable expense for patients undergoing long-term treatment. In overseas markets, the original version of mitotane is usually available in European and Turkish versions, and the price is about 9,000 yuan. However, due to different exchange rates and channels, the actual purchase price may vary.

In order to reduce the financial burden, some patients will choose overseas generic drugs, such as the generic version of mitotane produced in Laos. Its ingredients are basically the same as the original drug, and the specifications are the same500mg, 100 tablets, and the price per box is about more than 1,000 yuan. Although the price is lower, patients need to ensure that the drug is from a regular source when using it to ensure efficacy and safety.

Overall, mitotane plays an irreplaceable role in the treatment ofACC. Its domestic original drug is relatively expensive and not included in medical insurance, while overseas generic drugs provide a more economical option. During use, patients should develop an individualized medication plan under the guidance of a professional doctor, combined with blood drug concentration monitoring and clinical response assessment, to achieve safe and effective treatment.

Reference materials:https://go.drugbank.com/drugs/DB00648